Home / Lasmiditan / United States
US ATC N02CC08 · updated 2 Nov 2026
Lasmiditan shortage in United States
Is there a Lasmiditan shortage in United States?
Yes. As of 2 Nov 2026, 6 Lasmiditan products are reported short in United States, the first since 3 Nov 2025. No return date has been given. Main reason: not stated.
Not reported short in any other country we track. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Reyvow, Tablet, 100 mg (NDC 0002-4491-08) discontinuation | Eli Lilly and Co. | 3 Nov 2025 | not given | Not stated |
| US | Reyvow, Tablet, 100 mg (NDC 0002-4491-61) discontinuation | Eli Lilly and Co. | 3 Nov 2025 | not given | Not stated |
| US | Reyvow, Tablet, 100 mg (NDC 0002-4491-62) discontinuation | Eli Lilly and Co. | 3 Nov 2025 | not given | Not stated |
| US | Reyvow, Tablet, 50 mg (NDC 0002-4312-08) discontinuation | Eli Lilly and Co. | 3 Nov 2025 | not given | Not stated |
| US | Reyvow, Tablet, 50 mg (NDC 0002-4312-61) discontinuation | Eli Lilly and Co. | 3 Nov 2025 | not given | Not stated |
| US | Reyvow, Tablet, 50 mg (NDC 0002-4312-62) discontinuation | Eli Lilly and Co. | 3 Nov 2025 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).